The ICCM 2025: International Conference on Clinical Microbiology focuses on advancing clinical microbiology research, covering antimicrobial resistance, infection control, diagnostic innovations, and emerging infectious diseases.
Topics
- Pathogenesis
- Basic Science
- Biofilm
- Animal models including experimental treatment
- Antimicrobial pharmacokinetics, pharmacodynamics, pharmacogenomics,
- Antimicrobials
- Mechanisms of action and resistance
- pharmacoeconomics and general pharmacology, drug interaction studies
- Surveys of molecular epidemiology of resistance and resistance genes, strains or serotypes
- Resistance surveillance
- New antimicrobials
- In vitro antibacterial susceptibility
- Epidemiology of MDR-Gram-negatives
- Epidemiology of MRSA, VRE and other Gram-positives
- Molecular biology, including diagnostics
- Antibiotic usage
- Molecular virology
- Molecular bacteriology
- Molecular typing
- Molecular mycology
- Diagnostics, other than Molecular
- Molecular biology – others
- Methods for antibacterial susceptibility testing
- Diagnostic/laboratory methods other than molecular
- Public health and community-acquired infections
- Public Health
- Infection Control
- Emerging infectious diseases
- Travel Medicine, International Health, Tropical Diseases and Parasitology
- Clinical epidemiology of nosocomial infections
- Mycology
- Travel medicine, tropical and parasitic diseases
- Fungal infections
- Resistance and mechanisms of action of antifungals
- AIDS and HIV infection
- Virology
- Virology non-HIV/non-hepatitis
- Hepatitis
- Mycobacterial infections including diagnosis
- Clinical ID
- Community-acquired infections including CAP, sepsis, STD,
- Infection in the immunocompromised host and transplant recipients
- Antimicrobial clinical trials
- Lyme borreliosis, toxoplasmosis
- Vaccines and Immunology
- Paediatric infections
- Vaccines
- Immunology, host defences, immunotherapy
